2026年10月29日 6:13 ET 发布 · 更新于 16 天前 · 1 个来源
Eli Lilly is about to report earnings. Here's what to expect
CNBC Markets
·
原始报道
Eli Lilly is slated to report third-quarter earnings and revenue, which will likely be fueled by its obesity drug Zepbound and diabetes counterpart Mounjaro.
原文